News

Wegovy, Zepbound and the weight-loss drugs reshaping Americans
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...
Stung by high prices, Americans make their own weight-loss drugs
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
Crain's New York Business4dOpinion
Op-ed: Insurance companies must remove barriers to obesity treatments
Insurance companies should not drag their feet. They must take meaningful steps to ensure that obesity treatment is easily ...
New Orleans CityBusiness4d
Landry vetoes weight-loss drug insurance coverage for state employees, teachers
Gov. Jeff Landry vetoes a plan to cover costly weight-loss drugs for Louisiana state workers and teachers, citing long-term ...
TMCnet4d
Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety
Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy ...
New data show most patients now stay on Wegovy, Zepbound after a year
Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...
Devdiscourse5d
Staying the Course: New Data Shows Surging Persistence in Weight-Loss Drug Usage
Recent analysis of U.S. pharmacy claims reveals nearly two-thirds of patients who began weight-loss drugs Wegovy or Zepbound last year continued usage for a full year, up from previous years. Improved ...
Wegovy Prescriptions for Teens Are Up 50 Percent — Here’s What Parents Should Know
Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.